MedWatch

Bavarian Nordic brings in CEO of Innovation Fund Denmark

From April 1, Anne-Marie Levy Rasmussen will no longer be CEO at Innovation Fund Denmark, instead becoming the head of global commercial operations at biotech firm Bavarian Nordic.

CEO of Innovation Fund Denmark Anne-Marie Levy Rasmussen is joining Bavarian Nordic | Photo: Stine Bidstrup/ERH

After just three years as CEO of Innovation Fund Denmark, Anne-Marie Levy Rasmussen is leaving for greener pastures. On April 1, she joins Danish biotech company Bavarian Nordic as its new head of global commercial operations, the fund announces in a press release.

Before Levy Rasmussen started at Innovation Fund Denmark in February 2020, she had spent more than 12 years at pharmaceutical company Glaxosmithkline, and is now returning to the life science industry.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

CHMP to remove 100 generic medicines from market

Due to fraudulent clinical trials from a contract research organization, the EMA’s expert committee, the CHMP, is now suspending marketing approval authorizations for around 100 generic drugs on the market.

Further reading

Related articles

Latest news

See all jobs